On November 2, 2022 ALX Oncology Holdings Inc., ("ALX Oncology") (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, reported that management will participate in four upcoming investor conferences (Press release, ALX Oncology, NOV 2, 2022, View Source [SID1234622770]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 31st Annual Healthcare Conference
Format: Formal presentation
Date: Wednesday, November 9
Time: 9:50 AM Pacific Time/ 12:50 PM Eastern Time
Location: Rancho Palos Verdes, CA
Webcast link: Available here

Stifel 2022 Healthcare Conference
Format: Fireside chat with analyst, Bradley Canino
Date: Tuesday, November 15
Time: 3:00 PM Eastern Time
Location: New York, NY
Webcast link: Available here

Jefferies London Healthcare Conference
Format: Fireside chat with analyst, Michael Yee
Date: Thursday, November 17
Time: 2:40 PM Greenwich Mean Time/ 9:40 AM Eastern Time
Location: London, UK
Webcast link: Available here

Piper Sandler 34th Annual Healthcare Conference
Format: Fireside chat with analyst, Chris Raymond
Date: Tuesday, November 29
Time: 9:00 AM Eastern Time
Location: New York, NY
Webcast link: Will be made available on ALX Oncology website

A live webcast of the presentation and fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcasts will be archived for up to 90 days following the presentation and fireside chat dates.